9:45am ET
Health and Healthcare
Short Sellers Back Off Big Pharma
The short interest data have been released for the July 31 settlement date, and for most of the selected pharmaceutical stocks, short interest decreased.
Companies
/Healthcare
Pfizer Inc
$28.30
▼ $0.27 (−0.95%) today
Markets closed · 5:00am ET
PFE Coverage
Page 63
12:25pm ET
Investing
5 Defensive High-Yield Dividends That Should Withstand the Next Stock Market Correction
24/7 Wall St. maintains on its watch list a slew of defensive dividend stocks that investors flock to during periods of uncertainty. The trick is to know which companies are appropriate at…
4:01pm ET
Investing
The 4 Stocks That Dragged Down the DJIA on Thursday
thinkstockAugust 6, 2015: Markets opened higher again on Thursday but not by much and equities quickly turned south and remained in the red for the rest of the day. The report on…
8:35am ET
Health and Healthcare
4 Large Cap Pharmaceutical Stocks to Buy on Strong Health Care Trends
24/7 Wall St. screened the Merrill Lynch health care universe and found four pharmaceutical stocks rated Buy with outstanding short-term and long-term potential.
10:05am ET
Investing
4 Merrill Lynch Big, Old and Ugly Stocks to Buy for the Rest of 2015
ThinkstockFor the most part, unless you were way over-weighted to energy, large cap and mega cap stocks did reasonably well for investors this year. At the end of 2014 Savita Subramanian and…
8:54am ET
Investing
Top Analyst Upgrades and Downgrades: Amazon, Citrix, Gilead, Sirius XM, 3D Systems, Twitter, Yelp and Many More
Jon OggStocks were indicated higher on Wednesday ahead of the pending FOMC decision on interest rates. Tuesday’s rally was yet another instance where investors proved that they want to buy stocks after…
4:01pm ET
Investing
The 4 Stocks That Lifted the Dow on Tuesday
thinkstockJuly 28, 2015: Markets opened higher on Tuesday after the Shanghai market closed with a modest loss compared with Monday’s 8.5% dive. U.S. consumer confidence came in lower than expected and home…
7:42am ET
Health and Healthcare
Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs
ThinkstockPfizer Inc. (NYSE: PFE) reported second quarter 2015 results before markets opened Tuesday morning. The company reported quarterly adjusted diluted earnings per share (EPS) of $0.56 and revenues of $11.9 billion. In…
Paul Ausick 2:17pm ET
Health and Healthcare
What to Look For in Pfizer Earnings
Wikimedia CommonsBefore the market opens on Tuesday morning, Pfizer Inc. (NYSE: PFE) is scheduled to report second-quarter results. The company is expected to post earnings per share (EPS) of $0.52 on revenues…
Paul Ausick 8:21am ET
Health and Healthcare
Short Sellers Run For Cover From Major Pharma
ThinkstockThe short interest data have been released for the July 15 settlement date. Pharmaceutical companies are usually involved in a lengthy process in getting their drug candidates to market through clinical trials.…
10:21am ET
Health and Healthcare
BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead
ThinkstockPharmaceutical and Biotech investors are about to get a real show for earnings this week. Big Pharma will bring earnings from Dow Jones Industrial Average companies Merck & Co. Inc. (NYSE: MRK)…
10:20am ET
Health and Healthcare
3 Top Big Pharmaceutical Stocks With Upcoming Catalysts
A new report from Jefferies updates the firm's top global pharmaceutical stocks to buy, and these picks make sense for investors now.
8:05am ET
Health and Healthcare
Short Sellers Run for Cover in Big Pharma
The June 30 short interest data have been compared with the previous figures, and across the selected pharmaceutical stocks, short interest decreased.
4:01pm ET
Investing
The 4 Stocks That Boosted the DJIA on Thursday
thinkstockJuly 9, 2015: Markets opened higher on Thursday and that’s when the major indexes posted their daily highs. New claims for unemployment benefits remain at close to the averages for full employment…
8:55am ET
Health and Healthcare
3 UBS Must-Own Large-Cap Pharmaceutical Stocks
A new report from UBS highlights three stocks that the firm likes best now. Not only do they all pay a solid dividend and have a good potential for growth, they all…